Maquet Cardiovascular has obtained CE mark approval for its new Intergard Synergy antimicrobial vascular graft. The Intergard Synergy graft releases broad spectrum antimicrobial agents including silver acetate and triclosan from its ...
Tags: Maquet Cardiovascular, approval, antimicrobial vascular graft
Maquet Cardiovascular, a subsidiary of Swedish Getinge Group, has reported positive results from IABP- SHOCK II trial of its intra-aortic balloon counterpulsation (IABC) therapy, designed to reduce the workload of the heart and improve ...
Tags: IABC, percutaneous coronary intervention, AMI, Maquet Cardiovascular
Maquet Cardiovascular has gained US and European marketing rights for its new SENSATION PLUS 7.5Fr. 40Cc intra-aortic balloon (IAB) catheter, following the US Food and Drug Administration (FDA) and CE mark approvals respectively. The ...
Tags: marketing rights, catheter, FDA
Maquet Cardiopulmonary, a unit of Maquet Cardiovascular, has entered into an agreement to purchase Avalon Laboratories' Elite Bi-Caval Dual Lumen Catheter and complimentary vascular access kits for use during extracorporeal life support ...
Tags: Maquet, cardiopulmonary, ECLS